Kazia Therapeutics Limited. Key Management Personnel Compensation Postemployment Benefits
Kazia Therapeutics Limited. (KZIA) reported Key Management Personnel Compensation Postemployment Benefits of AUD 51.12 thousand for the 12-month period ending 2025-06-30, per its 20-F filed 2025-11-07.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits · last filed 2025-11-07
| Period end | Key Management Personnel Compensation Postemployment Benefits 12 month | Key Management Personnel Compensation Postemployment Benefits 12 month as first filed |
|---|---|---|
| 2025-06-30 | 51.12K AUD 20-F · filed 2025-11-07 | |
| 2024-06-30 | 72.78K AUD 20-F · filed 2025-11-07 | |
| 2023-06-30 | 149.63K AUD 20-F · filed 2025-11-07 | 150.00K AUD 20-F · filed 2023-10-26 |
| 2022-06-30 | 115.95K AUD 20-F · filed 2024-11-15 | 116.00K AUD 20-F · filed 2022-10-17 |
| 2021-06-30 | 112.00K AUD 20-F · filed 2023-10-26 | |
| 2020-06-30 | 97.00K AUD 20-F · filed 2022-10-17 | |
| 2019-06-30 | 84.00K AUD 20-F · filed 2021-10-07 | |
| 2018-06-30 | 90.00K AUD 20-F · filed 2020-10-22 | |
| 2017-06-30 | 155.00K AUD 20-F · filed 2019-10-21 | |
| 2016-06-30 | 130.00K AUD 20-F · filed 2018-10-24 |